tiprankstipranks
Advertisement
Advertisement

FBRX Stock Latest News

Forte Biosciences Prices $150 Million Public Offering
Company AnnouncementsForte Biosciences Prices $150 Million Public Offering
7d ago
8K
FBRX
Forte Biosciences 5.71M share Spot Secondary priced at $26.27
PremiumThe Fly
Forte Biosciences 5.71M share Spot Secondary priced at $26.27
7d ago
FBRX
Forte Biosciences announces common stock offering, no amount given
PremiumThe Fly
Forte Biosciences announces common stock offering, no amount given
7d ago
FBRX
Forte Biosciences reports FY25 EPS ($4.71) vs. ($12.17) last year
PremiumThe Fly
Forte Biosciences reports FY25 EPS ($4.71) vs. ($12.17) last year
15d ago
FBRX
Is FBRX a Buy, Before Earnings?
PremiumPre-Earnings
Is FBRX a Buy, Before Earnings?
25d ago
FBRX
Forte Biosciences initiated with an Outperform at Evercore ISI
PremiumThe FlyForte Biosciences initiated with an Outperform at Evercore ISI
5M ago
FBRX
Forte Biosciences Reports Increased R&D Costs Amid Clinical Progress
Premium
Company Announcements
Forte Biosciences Reports Increased R&D Costs Amid Clinical Progress
5M ago
FBRX
Forte Biosciences reports Q3 EPS (99c), consensus ($1.07)
Premium
The Fly
Forte Biosciences reports Q3 EPS (99c), consensus ($1.07)
5M ago
FBRX
Forte Biosciences Inc. Launches Promising Study on Alopecia Areata Treatment
PremiumCompany Announcements
Forte Biosciences Inc. Launches Promising Study on Alopecia Areata Treatment
6M ago
FBRX
Forte Biosciences Advances Celiac Disease Treatment with FB102 Study
PremiumCompany Announcements
Forte Biosciences Advances Celiac Disease Treatment with FB102 Study
6M ago
FBRX
Forte Biosciences’ FB102 Study: A Potential Breakthrough in Vitiligo Treatment
PremiumCompany Announcements
Forte Biosciences’ FB102 Study: A Potential Breakthrough in Vitiligo Treatment
6M ago
FBRX
Forte Biosciences Reports Q2 2025 Financial Results
PremiumCompany Announcements
Forte Biosciences Reports Q2 2025 Financial Results
8M ago
FBRX
Forte Biosciences initiated with a Buy at Guggenheim on FB102 potential
PremiumThe FlyForte Biosciences initiated with a Buy at Guggenheim on FB102 potential
8M ago
FBRX
Forte Biosciences initiated with a Buy at Guggenheim
Premium
The Fly
Forte Biosciences initiated with a Buy at Guggenheim
8M ago
FBRX
Forte Biosciences Announces Q2 2025 Results and Trials
Premium
Company Announcements
Forte Biosciences Announces Q2 2025 Results and Trials
8M ago
8K
FBRX
Forte Biosciences reports Q2 EPS (96c), consensus ($1.11)
PremiumThe Fly
Forte Biosciences reports Q2 EPS (96c), consensus ($1.11)
8M ago
FBRX
Sixteen new option listings on July 23rd
PremiumThe Fly
Sixteen new option listings on July 23rd
9M ago
RAL
SMU
Forte Biosciences Announces Public Offering of Shares
PremiumCompany Announcements
Forte Biosciences Announces Public Offering of Shares
10M ago
8K
FBRX
Forte Biosciences announces common stock offering, no amount given
PremiumThe Fly
Forte Biosciences announces common stock offering, no amount given
10M ago
FBRX
Forte Biosciences Stock (FBRX) Surges 25% on Positive Celiac Disease Trial Data
PremiumMarket NewsForte Biosciences Stock (FBRX) Surges 25% on Positive Celiac Disease Trial Data
10M ago
FBRX
Forte Biosciences Announces Positive Phase 1b Trial Results
Premium
Company Announcements
Forte Biosciences Announces Positive Phase 1b Trial Results
10M ago
8K
FBRX
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
10M ago
ACN
AMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >